ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,958Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 17

$675K Total Retail Price of All Prescriptions

Rank: 3 out of 17

533 Patients Receiving at Least One Drug in Part D
31%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 533 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

41% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 22%.

Risky Drugs to Seniors

2% of this provider’s 3,923 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $47 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,237 267 S3 1 1
AMLODIPINE BESYLATE 393 190 2 3
METHADONE HCL 332 62 S2 3 59
GABAPENTIN 296 71 4 16
FOSINOPRIL SODIUM 270 140 5 84
PRAVASTATIN SODIUM 259 126 6 11
TRAMADOL HCL 247 71 7 13
MORPHINE SULFATE ER 245 29 S2 8 89
CYCLOBENZAPRINE HCL 228 15 R 9 30
RANITIDINE HCL 225 134 10 37
NEXIUM 224 66 11 19
HYDROCHLOROTHIAZIDE 223 80 12 10
METFORMIN HCL 201 75 13 5
OMEPRAZOLE 197 129 14 4
METOPROLOL TARTRATE 177 67 15 9
CLONIDINE HCL 153 36 16 15
FUROSEMIDE 150 62 17 7
SIMVASTATIN 143 72 18 2
DOXAZOSIN MESYLATE 142 84 19 108
ATENOLOL 139 88 20 22
SPIRIVA 128 67 21 64
SPIRONOLACTONE 126 69 22 72
LISINOPRIL-HYDROCHLOROTHIAZIDE 121 34 23 21
LEVOTHYROXINE SODIUM 121 64 23 6
AMITRIPTYLINE HCL 120 27 R 25 61
PROAIR HFA 116 59 26 70
LOSARTAN POTASSIUM 108 56 27 14
TRAZODONE HCL 108 33 27 46
LISINOPRIL 107 45 29 8
MELOXICAM 101 27 30 23
POTASSIUM CHLORIDE 98 61 31 12
CITALOPRAM HBR 92 35 32 35
VERAPAMIL ER 90 48 33 47
ZOLPIDEM TARTRATE 89 16 34 24
OXYCONTIN 88 0 S2 35 103
FLUTICASONE PROPIONATE 87 18 36 41
ADVAIR DISKUS 80 35 37 62
METHOCARBAMOL 80 0 R 37 110
OXYCODONE HCL 75 26 S2 39 132
NAPROXEN 72 13 40 66
FLUOXETINE HCL 71 17 41 71
LYRICA 68 0 42 94
ALLOPURINOL 67 42 43 31
PROMETHAZINE HCL 65 0 R 44 54
CARVEDILOL 65 29 44 18
OXYBUTYNIN CHLORIDE 65 36 44 138
IBUPROFEN 64 0 47 49
GLIPIZIDE 58 28 48 90
VENLAFAXINE HCL 58 0 48 145
NOVOLIN 70-30 57 37 50 147
CLOPIDOGREL 53 27 51 29
TRIAMTERENE-HCTZ 53 21 51 57
INSULIN SYRINGE 52 30 53 63
ACETAMINOPHEN-CODEINE 51 25 S3 54 69
FENTANYL 50 0 S2 55 115
BUSPIRONE HCL 50 0 55 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.